Reviva Pharmaceuticals Holdings, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $23.7M
Liabilities Breakdown FY2023
Total Liabilities: $18.0M
Asset Breakdown
Total Assets: $23.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.4M | 98.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $332.9K | 1.4% |
Liabilities Breakdown
Total Liabilities: $18.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.8M | 21.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.1M | 78.6% |